544 related articles for article (PubMed ID: 32123532)
41. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
42. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
43. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
44. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
Zheng X; Xu M; Yao B; Wang C; Jia Y; Liu Q
Cell Signal; 2016 Sep; 28(9):1314-1324. PubMed ID: 27297362
[TBL] [Abstract][Full Text] [Related]
45. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.
Liu Y; Liu L; Zhou Y; Zhou P; Yan Q; Chen X; Ding S; Zhu F
Clin Cancer Res; 2019 Jul; 25(13):4141-4154. PubMed ID: 30918019
[TBL] [Abstract][Full Text] [Related]
46. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
50. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T
Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668
[TBL] [Abstract][Full Text] [Related]
51. Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516.
Li O; Li Z; Tang Q; Li Y; Yuan S; Shen Y; Zhang Z; Li N; Chu K; Lei G
Med Sci Monit; 2018 Nov; 24():8510-8523. PubMed ID: 30472720
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
53. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
54. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
55. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
56. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
[TBL] [Abstract][Full Text] [Related]
57. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
Li SJ; Sui MH; Sun ZX; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
[TBL] [Abstract][Full Text] [Related]
58. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
59. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
60. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
